ClinicalTrials.gg
Not yet recruitingNCT07478081HF-mHealthUpdated Mar 20, 2026

mHealth Intervention to Support Self-care During the Hospital to Home Transition in Individuals With Heart Failure

An interventional study of mHealth Educational Self-Management Application and Usual transitional care in Heart Failure, Self-care and Transitional Care, sponsored by Universidad de la Sabana. Not yet recruiting at 1 site in Colombia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-20.

Sponsored by Universidad de la Sabana · Not applicable, Interventional, and Health services research

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 39 studies in Heart Failure with a site in Colombia — 7 open to participants now, 9 under way, 5 of them phase 3. Heart Failure · Colombia.

Planned enrollment
32nd of 34
30 · median 3,388
Started
2026
with 1 other
No phase
9 of 39
2 open now
Registered
38th of 39
by date
Lead sponsor
2 of 39
Universidad de la Sabana

Among the 39 studies in Heart Failure with a site in Colombia, this one is the 32nd largest by planned enrollment of the 34 interventional ones that give a count, is one of 2 that started in 2026, is one of 9 with no phase, and was the 38th registered.

Heart Failure

6,340 studies on the registry are indexed under Heart Failure; 1,397 are open to participants now.

Browse Heart Failure studies →

Open to participants now

7 of the 39 studies in Heart Failure with a site in Colombia are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Colombia have not opened yet or have stopped. Only those recruiting at a site in Colombia →

Who these studies take

Of the 968 Heart Failure studies recruiting now, 691 (71%) set no upper age limit and 90 (9%) stop at 75 or younger; 64 take children under 18; 97 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 39 studies in Heart Failure with a site in Colombia, or all of them as a file.
02

Study summary

This study is a pilot randomized controlled trial designed to evaluate the feasibility, acceptability, usability, and preliminary efficacy of a mobile health (mHealth) educational self-management intervention for individuals with heart failure during the transition from hospital to home. Participants will be randomly assigned in a 1:1 ratio to receive either usual care alone or usual care plus the mHealth intervention.

The mobile application is designed to support heart failure self-care through tailored educational content, symptom self-monitoring, automated feedback, behavioral reinforcement messages, caregiver involvement, and secure communication with the healthcare team. The application is educational in nature and does not replace standard medical treatment.

A total of 30 participants will be enrolled and followed for 60 days after hospital discharge, with outcome assessments conducted at 30 and 60 days. Primary outcomes focus on feasibility, technology acceptance, and usability of the intervention. Secondary exploratory outcomes include changes in self-care behaviors, functional status, heart failure related hospital readmissions and natriuretic peptide levels. Results from this pilot study will inform the design of a future definitive randomized controlled trial.

Read the detailed description

This is an interventional, randomized, controlled, parallel-group pilot trial with a 1:1 allocation ratio designed to evaluate the feasibility, acceptability, usability, and preliminary efficacy of a mobile health (mHealth) educational self-management intervention for individuals with heart failure during the hospital-to-home transition. The study uses a single-blind design in which outcome assessors are blinded to group assignment. The intervention is behavioral and educational in nature; therefore, the study phase is classified as not applicable.

The study will be conducted at a tertiary cardiovascular referral institution. Participants will be recruited from inpatient cardiology services prior to hospital discharge and followed for 60 days after hospital discharge, with outcome assessments conducted at 30 and 60 days.

Eligible participants include adults aged 18 years or older with a diagnosis of heart failure (New York Heart Association class II or III), who are clinically stable at discharge, own a compatible smartphone, demonstrate basic digital literacy, and have an informal caregiver willing to support the intervention. Key exclusion criteria include life expectancy less than 6 months, severe cognitive impairment, inability to provide informed consent, or participation in another interventional study.

Participants will be randomly assigned (1:1) using computer-generated block randomization with variable block sizes of 4 and 6. The allocation sequence will be generated by an independent researcher not involved in recruitment or outcome assessment. Allocation concealment will be ensured through sequentially numbered, opaque, sealed envelopes.

Two study arms are defined:

Participants in the usual care group will receive standard hospital to home transitional care according to institutional protocols, including multidisciplinary discharge education, medication reconciliation, and scheduled outpatient follow-up.

Participants in the experimental group will receive usual care plus the mHealth educational self-management intervention. The intervention consists of a mobile application developed prior to study initiation and designed to strengthen heart failure self-care. Core components include tailored educational modules, symptom self-monitoring, automated feedback, behavioral reinforcement messages, caregiver integration, and secure communication with the healthcare team.

The intervention will be delivered over a 60-day period following hospital discharge. Implementation begins prior to discharge with application installation and guided education involving both the participant and caregiver. After discharge, the intervention includes intensive monitoring during week 1, reinforcement and on-demand contact during weeks 2-4, and automated monitoring with digital feedback from week 5 through day 60 post-discharge, with follow-up assessments conducted at 30 and 60 days..

Primary outcomes assess feasibility of trial procedures, technology acceptance using the technology acceptance model scale, and usability of the mobile application using the system usability scale and a user-centered cognitive walkthrough. Secondary exploratory outcomes include change in self-care measured with the Self Care of Heart Failure Index (SCHFI v7.2), heart failure-related hospital readmissions, change in New York Heart Association functional class, and change in NT-proBNP levels.

03

Conditions studied

  • Heart Failure
  • Self-care
  • Transitional Care

Browse trials for

Keywords

  • mHealth
  • Heart Failure
  • Transitional Care
  • Patient Education
  • Self-Management
  • Self-care
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18 years
  • Diagnosis of heart failure ( Class II or III)
  • Clinically stable at discharge (no IV inotropes within 48 hours; hemodynamically stable)
  • Ownership of compatible smartphone (Android/iOS)
  • Basic digital literacy
  • Availability of informal caregiver willing to support the process

Exclusion criteria

Exclusion Criteria:

  • \< 6 months
  • Severe cognitive impairment ( \<24 or documented dementia)
  • Inability to provide
  • Participation in another interventional study
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Active comparator
    Usual Care

    Participants will receive standard hospital to home transitional care, including multidisciplinary discharge education, medication reconciliation, and scheduled outpatient follow-up according to institutional protocols.

    Other: Usual transitional care

  • Experimental
    mHealth educational self-management intervention

    Participants will receive a mobile health (mHealth) educational self-management intervention in addition to usual care. The intervention consists of a mobile application designed to support heart failure self-care through tailored educational modules, symptom self-monitoring, automated feedback, behavioral reinforcement messages, caregiver integration, and secure communication with the healthcare team over a 60-day period following hospital discharge.

    Behavioral: mHealth Educational Self-Management Application

Interventions

  • BehavioralmHealth Educational Self-Management Application

    A structured mobile health educational and self-management intervention delivered through a smartphone application. The intervention provides tailored heart failure education, daily and weekly symptom monitoring, automated reinforcement messages, caregiver engagement tools, and communication support with the healthcare team. The intervention is educational in nature and does not function as a regulated medical device.

  • OtherUsual transitional care

    Standard multidisciplinary hospital discharge education, medication reconciliation, and scheduled outpatient follow-up provided according to institutional protocols.

06

What researchers measure

Primary outcomes

  1. Recruitment rate

    Proportion of eligible participants who are enrolled and randomized in the trial

    Time frame: From screening until completion of recruitment

  2. Retention rate

    Proportion of randomized participants who complete follow-up assessments

    Time frame: 30 and 60 days post-discharge

  3. Adherence to the mHealth intervention

    Proportion of educational modules completed and symptom self-monitoring entries recorded in the application logs.

    Time frame: 30 and 60 days post-discharge

  4. Data completeness

    Percentage of completed outcome assessments among enrolled participants

    Time frame: 30 and 60 days post-discharge

  5. Time required for enrollment and intervention delivery

    Time required to complete enrollment procedures and initial intervention delivery, measured in minutes.

    Time frame: At enrollment

Secondary outcomes

  1. Technology Acceptance of the Mobile Application (TAM)

    Technology acceptance will be measured using the Technology Acceptance Model (TAM) scale, an 11 item instrument assessing perceived usefulness, perceived ease of use, and behavioral intention to use the application. Items are rated on a 5 point Likert scale (1 = strongly disagree to 5 = strongly agree). Results will be reported as mean total score and mean subscale scores.

    Time frame: 60 days post-discharge

  2. Usability of the Mobile Application

    Usability will be assessed using two complementary methods: (a) System Usability Scale (SUS), a 10 item questionnaire scored from 0 to 100 and reported as mean total score and (b) User-Centered Cognitive Walkthrough (UC-CW), evaluating task completion rate, number and type of navigation errors, and functional understanding issues.

    Time frame: 30 days post-discharge

  3. Change in Self-Care (SCHFI v7.2)

    Self-care will be measured using the Self-Care of Heart Failure Index (SCHFI v7.2), which provides standardized scores (0-100) for maintenance, symptom perception, and management subscales. The primary metric will be change from baseline, 30 days and 60 days post-discharge

    Time frame: Baseline, 30 days and 60 days post-discharge

Other outcomes

  1. Heart Failure Related Hospital Readmissions

    Number and proportion of participants readmitted due to heart failure decompensation, verified through institutional medical record review.

    Time frame: 30 and 60 days post-discharge

  2. Change in NYHA Functional Class

    Change in New York Heart Association (NYHA) functional class (I-IV), reported as proportion improved, unchanged, or worsened from baseline, 30 days and 60 days post-discharge

    Time frame: Baseline, 30 days and 60 days post-discharge

  3. Change in NT-proBNP Levels

    Change in NT-proBNP plasma levels (pg/mL), measured using institutional laboratory standard methods, reported as mean change from baseline to 30 days and 60 days post-discharge

    Time frame: Baseline, 30 days and 60 days post-discharge

07

Study locations

1 site
  • Centro Cardiovascular Colombiano SAS
    Bogotá, Bogota D.C. 0907, Colombia
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data will be shared, including demographic and baseline clinical variables, group assignment, feasibility outcomes, technology acceptance, usability measures, self-care outcomes, NYHA functional class, NT-proBNP levels, and heart failure-related readmissions. Data will be made available upon reasonable request from qualified investigators for academic and non-commercial research purposes.

Supporting information: Study protocol, Statistical analysis plan, Analytic code

Time frame: Data will be available beginning 6 months after publication of the primary results and will remain available for a minimum of 5 years.

Access criteria: Qualified researchers may request access by contacting the principal investigator. Requests must include a brief proposal, analysis plan, and a data use agreement. Data will be shared in a de-identified format through a secure institutional repository.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2026; primary completion for Jun 2027, 15 months later.

Of 1,119 non-industry interventional studies with no phase under Heart Failure, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 50. This study's planned 15 months is below that.

Counting every sponsor, half of 1,355 studies reached it within 31 months; a quarter within 16 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 19, 2026
First posted
Mar 17, 2026
StartEst.
Mar 2026
Primary completionEst.
Jun 2027
CompletionEst.
Jun 2027
Last update
Mar 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07478081
Lead sponsor
Universidad de la Sabana
Responsible party
Sponsor
First posted
Mar 17, 2026
Start date
Mar 2026 (estimated)
Primary completion
Jun 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Mar 20, 2026

Study contacts

Diana M Achury
Contact
dianaachsa@unisabana.edu.co
+57 3154847549

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion